| Foxp3 expression in human cancer cells V Karanikas, M Speletas, M Zamanakou, F Kalala, G Loules, T Kerenidi, ... Journal of translational medicine 6, 1-8, 2008 | 271 | 2008 |
| VEGF, TNF-α and 8-isoprostane levels in exhaled breath condensate and serum of patients with lung cancer E Dalaveris, T Kerenidi, A Katsabeki-Katsafli, T Kiropoulos, K Tanou, ... Lung cancer 64 (2), 219-225, 2009 | 134 | 2009 |
| Indoleamine 2, 3-dioxygenase (IDO) expression in lung cancer V Karanikas, M Zamanakou, T Kerenidi, J Dahabreh, A Hevas, M Nakou, ... Cancer biology & therapy 6 (8), 1269-1268, 2007 | 99 | 2007 |
| Hypoxia inducible factor-1 alpha and vascular endothelial growth factor in biopsies of small cell lung carcinoma. M Ioannou, R Papamichali, E Kouvaras, I Mylonis, D Vageli, T Kerenidou, ... Lung 187 (5), :321-9, 2009 | 59 | 2009 |
| Serum vascular endothelial growth factor is related to systemic oxidative stress in patients with lung cancer A Katsabeki-Katsafli, T Kerenidi, K Kostikas, E Dalaveris, TS Kiropoulos, ... Lung Cancer 60 (2), 271-276, 2008 | 55 | 2008 |
| Clinical significance of serum adipokines levels in lung cancer T Kerenidi, M Lada, A Tsaroucha, P Georgoulias, P Mystridou, ... Medical Oncology 30, 1-8, 2013 | 48 | 2013 |
| Poly (A)-specific ribonuclease and Nocturnin in squamous cell lung cancer: prognostic value and impact on gene expression P Maragozidis, E Papanastasi, D Scutelnic, A Totomi, I Kokkori, ... Molecular cancer 14, 1-12, 2015 | 43 | 2015 |
| Systemic oxidative stress in patients with pulmonary sarcoidosis A Koutsokera, AI Papaioannou, F Malli, TS Kiropoulos, A Katsabeki, ... Pulmonary pharmacology & therapeutics 22 (6), 603-607, 2009 | 32 | 2009 |
| Anti-survivin antibody responses in lung cancer V Karanikas, S Khalil, T Kerenidi, KI Gourgoulianis, AE Germenis Cancer letters 282 (2), 159-166, 2009 | 32 | 2009 |
| Co-expression patterns of tumor-associated antigen genes by non-small cell lung carcinomas: implications for immunotherapy V Karanikas, S Tsochas, K Boukas, T Kerenidi, M Nakou, J Dahabreh, ... Cancer biology & therapy 7 (3), 345-352, 2008 | 29 | 2008 |
| Long-term respiratory follow-up of H1N1 infection P Zarogoulidis, G Kouliatsis, N Papanas, D Spyratos, TC Constantinidis, ... Virology Journal 8, 1-8, 2011 | 28 | 2011 |
| Differential expression of hypoxia-inducible factor 1α in non-small cell lung cancer and small cell lung cancer E Karetsi, MG Ioannou, T Kerenidi, M Minas, PA Molyvdas, ... Clinics 67 (12), 1373-1378, 2012 | 27 | 2012 |
| Vibration response imaging: evaluation of rater agreement in healthy subjects and subjects with pneumonia K Bartziokas, C Daenas, S Preau, P Zygoulis, A Triantaris, T Kerenidi, ... BMC medical imaging 10, 1-8, 2010 | 27 | 2010 |
| The annual direct costs of stable COPD in Greece E Stafyla, M Geitona, T Kerenidi, A Economou, Z Daniil, KI Gourgoulianis International Journal of Chronic Obstructive Pulmonary Disease, 309-315, 2018 | 26 | 2018 |
| Everyday clinical practice and its relationship to 2010 and 2011 GOLD guideline recommendations for the management of COPD. M Papala, N Kerenidi, KI Gourgoulianis Prim Care Respir J 22 (3), :362-4., 2013 | 25 | 2013 |
| Clinical significance of circulating osteopontin levels in patients with lung cancer and correlation with VEGF and MMP-9 T Kerenidi, AP Kazakou, M Lada, I Tsilioni, Z Daniil, KI Gourgoulianis Cancer Investigation 34 (8), 385-392, 2016 | 24 | 2016 |
| A qualitative content analysis of spirituality and religiosity amongst Greek COPD patients E Tzounis, T Kerenidi, Z Daniil, C Hatzoglou, E Kotrotsiou, ... Religions 7 (3), 22, 2016 | 23 | 2016 |
| Mesothelioma mortality in Greece from 1983 to 2003 E Gogou, T Kerenidi, V Chamos, E Zintzaras, KI Gourgoulianis International journal of clinical practice 63 (6), 944-948, 2009 | 22 | 2009 |
| Baseline levels of CD8+ T cells against survivin and survivin-2B in the blood of lung cancer patients and cancer-free individuals V Karanikas, F Soukou, F Kalala, T Kerenidi, ES Grammoustianou, ... Clinical immunology 129 (2), 230-240, 2008 | 21 | 2008 |
| Sestrin-2 is significantly increased in malignant pleural effusions due to lung cancer and is potentially secreted by pleural mesothelial cells I Tsilioni, AS Filippidis, T Kerenidi, AV Budanov, SG Zarogiannis, ... Clinical Biochemistry 49 (9), 726-728, 2016 | 20 | 2016 |
